This result further confirmed that the serum SIA content might be one of the potential early-stage biomarkers to reflect the intrauterine fetal inflammatory response, whose sensitivity within 1 h after birth was prior to that of CRP, and it might play a guiding role in the early postnatal anti-infection treatments. This evidence concerns the gene CRP and infection.